Back

The phospholamban (PLN) p.Arg14del risk model; Longitudinal validation and reevaluation of predictors regarding sudden cardiac death (SCD)

16 April 2023 (08:40 - 09:40)
Organised by:
Congress Presentation Part of: ePoster session 2 Device Treatment EHRA Premium Access EHRA 2023

About the speaker

Photo
Miss Myrthe Van Der Heide

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

9 More presentations in this session

Presentation thumbnail
Weight-loss management after catheter ablation of atrial fibrillation
Miss A. Burbelka (Rzeszow, PL)
Abstract Slides
Presentation thumbnail
Cardiac hereditary diseases: genetic insights from a single center 15-year experience
Doctor A. Porretta (Paris, FR)
Abstract Slides
Presentation thumbnail
The safety and efficacy of rotor ablation in right atrium after pulmonary vein isolation in patients with persistent atrial fibrillation
Doctor A. Yoshida (Ono, JP)
Abstract Slides
Presentation thumbnail
Pitfalls and limitations in the assessment of the HV interval in a transcatheter aortic valve replacement population. A prospective analysis.
Doctor C. Teres (Lausanne, CH)
Abstract Slides
Presentation thumbnail
Lesion formation in irrigated RF-ablation is not linear, but monoexponential
Doctor F. Bahlke (Munich, DE)
Abstract Slides

Access the full session

Session thumbnail
ePoster session 2

The Event

Event poster

EHRA 2023

16 April 2023 08:40 CET
You may be interested in
thumbnail
Congress Session
Ventricular storm (2)
thumbnail
Congress Session
The storm will pass…
thumbnail
Congress Session
Ventricular tachycardia ablation in challenging scenarios: case-based management strategies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources